Loading...

LABIANA PHARMACEUTICALS IMPLEMENTS THE NEW EU PHARMACEUTICAL SERIALIZATION REQUIREMENT

Home / Sin categoría / LABIANA PHARMACEUTICALS IMPLEMENTS THE NEW EU PHARMACEUTICAL SERIALIZATION REQUIREMENT

Labiana Pharmaceuticals, as part of the pharmaceutical sector in Europe, successfully implemented the process of serialization or unit identification of medicinal products.

The new EU regulation 2016/161, which completes the Directive 2001/83/C (Directive on Falsified Medicines of the European Union – EU FMD), entered into force on 9 February 2019.

More than 5,000 European pharmaceutical laboratories have been required to adapt to this new regulation against the counterfeiting of medicines. At Labiana we fulfilled the requirement of serialization and data logging requiring the unit identification code, which will be printed on each medicinal product.

At Labiana Pharmaceuticals we chose one of the best and most recognized technologies available today in the market, with the aim of guaranteeing a complete and continuous service.

Thanks to this important investment, we can assure our customers that Labiana fulfils all the serialization requirements.

Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle información relacionada con sus preferencias, mediante el análisis de sus hábitos de navegación. Si continúa navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información visitando nuestra Política de Cookies

We use own and third-party cookies to improve our services and show information related to your preferences by analyzing your browsing habits. If you continue browsing, we will consider that you allow us to use them. You can change the settings or get more information on our Cookies policy

Nous utilisons nos propres cookies et celles de tiers pour améliorer nos services et vous proposer des informations relatives à vos préférences, en analysant vos habitudes de navigation. Si vous poursuivez la navigation, nous estimons que vous acceptez l’utilisation des cookies. Vous pouvez modifier les paramètres ou obtenir plus d'informations en nous rendant visite sur notre politique relative aux cookies

ACEPTAR
Aviso de cookies